Krilogy Financial’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,717
Closed -$210K 1029
2025
Q4
$210K Sell
2,717
-1,534
-36% -$121K 0.01% 856
2025
Q3
$334K Buy
+4,251
New +$335K 0.01% 644
2018
Q4
Sell
-428
Closed -$20K 459
2018
Q3
$20K Buy
+428
New +$19.6K ﹤0.01% 429
2018
Q2
Sell
-2,147
Closed -$99K 439
2018
Q1
$99K Sell
2,147
-184
-8% -$8.93K 0.02% 234
2017
Q4
$118K Sell
2,331
-803
-26% -$42.3K 0.03% 205
2017
Q3
$163K Sell
3,134
-855
-21% -$41.6K 0.04% 182
2017
Q2
$195K Buy
3,989
+2,423
+155% +$112K 0.05% 146
2017
Q1
$75K Hold
1,566
0.02% 238
2016
Q4
$75K Sell
1,566
-266
-15% -$12.2K 0.02% 238
2016
Q3
$73K Hold
1,832
0.02% 249
2016
Q2
$65K Hold
1,832
0.02% 268
2016
Q1
$72K Sell
1,832
-176
-9% -$6.58K 0.03% 218
2015
Q4
$86K Sell
2,008
-113
-5% -$4.97K 0.08% 97
2015
Q3
$89K Buy
+2,121
New +$99.1K 0.04% 147

Other funds holding MET

Krilogy Financial's MET Position: Q1 2026 in Review

Krilogy Financial sold out of MetLife (MET) in Q1 2026, closing a stake of 2,717 shares — an estimated $210K sold.

Krilogy Financial first reported a position in MET in Q3 2015 and held it in 14 quarters. The position peaked at $334K in Q3 2025. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Krilogy Financial reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
  • Krilogy Financial sold 2,717 MetLife shares in Q1 2026, an estimated $210K.
  • Krilogy Financial first reported a position in MetLife in Q3 2015 and held it in 14 quarters.
  • Krilogy Financial's MetLife position peaked at $334K in Q3 2025.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Krilogy Financial's 13F filing for Q1 2026, filed 17 Apr 2026.